XOPENEX HFA Rx

Select the drug indication to add to your list

XOPENEX HFA

Asthma/COPD
Only 4 drugs may be compared at once

Generic Name and Formulations:

Levalbuterol (as tartrate) (single-isomer albuterol) 45mcg/inh; metered dose inhaler; CFC-free.

Company:

Sunovion

Select therapeutic use:

Indications for XOPENEX HFA:

Bronchospasm.

Adults and Children:

<4yrs: not established. ≥4yrs: 2 inh every 4–6hrs; or 1 inh every 4hrs may suffice.

Warnings/Precautions:

Do not exceed recommended dose. Monitor for increased need; if inadequate control, reevaluate and consider adding an antiinflammatory (eg, corticosteroids). Sensitivity to sympathomimetics. Discontinue if paradoxical bronchospasm or cardiovascular effects occur. Cardiovascular disorders (esp. coronary insufficiency, arrhythmias, hypertension). Seizure disorders. Diabetes. Hyperthyroidism. Renal impairment; monitor (esp. in elderly). Elderly. Labor & delivery. Pregnancy. Nursing mothers.

Interactions:

Avoid within 2 weeks of MAOIs, tricyclic antidepressants. Avoid other short-acting sympathomimetic aerosol bronchodilators, epinephrine. Antagonized by β-blockers. Caution with other drugs that may lower serum potassium (eg, diuretics). Monitor digoxin.

See Also:

XOPENEX

XOPENEX CONCENTRATE

Pharmacological Class:

Beta-2 agonist.

Adverse Reactions:

Accidental injury, bronchitis, dizziness, pain, pharyngitis, rhinitis, vomiting; paradoxical bronchospasm, hypersensitivity reactions, cardiovascular effects, hypokalemia.

Generic Availability:

Vials (YES); HFA (NO)

How Supplied:

Inhaler w. actuator (80inh)—8.4g, (200 inh)—15g; Soln 0.31mg/3mL, 0.63mg/3mL, 1.25mg/3mL—24 vials; Concentrate 1.25mg/0.5mL—30 vials

XOPENEX HFA 15g of 45mcg inhalers (Qty:1)

appx. price $76.00